Sandoz Group AG SANDOZ GROUP ORD SHS
Sandoz Group AG SANDOZ GROUP ORD .../ CH1243598427 /
0SAN
2024-09-02 9:19:26 AM
|
Chg.
-0.40
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
37.13CHF
|
-1.06%
|
131 Turnover: 4,864.03 |
-Bid Size: - |
-Ask Size: - |
16.89 bill.CHF |
- |
- |
Business description
Sandoz is a global leader in off-patent medicines, with the purpose to pioneer access for patients.
Management board & Supervisory board
CEO |
Richard Saynor |
Management board |
Colin Bond |
Supervisory board |
Gilbert Ghostine, Dr. Karen J. Huebscher, Maria Varsellona, Urs Riedener, Dr. Shamiram R. Feinglass, Aarti Shah, PhD, Yannis Skoufalos, Remco Steenbergen |
Company data
Name: |
Sandoz Group N |
Address: |
Forum 1 Novartis Campus CH-4056,Basel |
Phone: |
+41 61 324 11 11 |
Fax: |
+41 61 324 11 11 |
E-mail: |
-
|
Internet: |
https://www.sandoz.com/ |
Industry: |
Healthcare |
Sector: |
Pharmaceutical Industry |
Sub sector: |
Pharmaceuticals |
End of financial year: |
12-31 |
Free Float: |
- |
IPO date: |
2023-10-04 |